Get the latest news on Avax Technologies stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on AVXT performance

Latest Avax Technologies Stock News | OTC:AVXT | Benzinga

Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It is also involved in the development and commercial readiness in the immuno-oncology arena.

News

Intraday Update

Markets

Movers

Trading Ideas

ALVVF

APPS

APRO

ATEC

AURI

AVXT

BBBXF

BLHEY

BMCH

CBOE

CETV

CHPGF

CINF

CLSI

CMXC

CNMD

COLD

CONC

CUBE

CVNA

CYRX

DPMLF

EVRG

FERN

GMAB

GNMSF

GOLD

GRWG

HLND

IMOS

ITMC

MIRM

MISVF

MXSG

Nuveen Insured Tax-Free Advantage Municipal Fund

Nuveen Insured New York Tax-Free Advantage Municipal Fund

NSRGF

Nestle Sponsored representing Registered Shares Series B

NSRGY

Nuveen Insured Dividend Advantage Municipal Fund

Nuveen New Jersey Dividend Advantage Municipal Fund

Nuveen Dividend Advantage Municipal Fund 3

ORZCF

PERI

PFGC

PMSNF

PODD

PRNB

RGLD

RNSGF

ROGFF

ROKU

SEDG

SLVRF

SWCH

TCEGF

TMCX

TNAV

TORXF

TRXD

WELL

WKLDF

PSTO

CSPCY

TRZBF

SILV

Stocks That Hit 52-Week Highs Of Monday

AVAX TECHS INC by AVAX Technologies, Inc.

Avax Technologies Inc

Avax Technologies

Comments

Avax Technologies Stock News

News

Latest Avax Technologies Stock News | OTC:AVXT | Benzinga

Monday, August 12, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga